BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6131166)

  • 1. Allogeneic bone-marrow transplantation in infantile malignant osteopetrosis.
    Sieff CA; Chessells JM; Levinsky RJ; Pritchard J; Rogers DW; Casey A; Muller K; Hall CM
    Lancet; 1983 Feb; 1(8322):437-41. PubMed ID: 6131166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation for infantile malignant osteopetrosis.
    Solh H; Da Cunha AM; Giri N; Padmos A; Spence D; Clink H; Ernst P; Sakati N
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):350-5. PubMed ID: 7583393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation in an osteopetrosis patient: first report in Thailand.
    Hongeng S; Pakakasama S; Chuansumrit A; Rerkamnuaychoke B; Nitiyanunt P; Suthutvoravut U; Ungkanont A; Hathirat P
    Asian Pac J Allergy Immunol; 1998 Dec; 16(4):193-8. PubMed ID: 10219901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic stem cell transplantation for 8 patients with malignant infantile osteopetrosis in China].
    Zhu GH; Qin MQ; Wang B; Zhou X; Yang J; Jia CG; Wu Y; Wang XS; Wu MY
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):807-12. PubMed ID: 23302608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group.
    Gerritsen EJ; Vossen JM; Fasth A; Friedrich W; Morgan G; Padmos A; Vellodi A; Porras O; O'Meara A; Porta F
    J Pediatr; 1994 Dec; 125(6 Pt 1):896-902. PubMed ID: 7996361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis.
    Behfar M; Dehghani SS; Hosseini AS; Jalali A; Hamidieh AA; Ghavamzadeh A
    Pediatr Transplant; 2015 Jun; 19(4):422-7. PubMed ID: 25879376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful unrelated mismatched cord blood transplantation in a child with malignant infantile osteopetrosis.
    Jaing TH; Hou JW; Chen SH; Huang IA; Wang CJ; Lee WI
    Pediatr Transplant; 2006 Aug; 10(5):629-31. PubMed ID: 16857002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of malignant infantile osteopetrosis before and after bone marrow transplantation.
    Cheow HK; Steward CG; Grier DJ
    Pediatr Radiol; 2001 Dec; 31(12):869-75. PubMed ID: 11727023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor.
    Locatelli F; Bongiorno M; Zecca M; Giani S; Giorgiani G; Guagnini R; Morandi P; Porta F; Nespoli L; Burgio GR
    Bone Marrow Transplant; 1991; 7 Suppl 3():124-7. PubMed ID: 1855074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation.
    Dini G; Floris R; Garaventa A; Oddone M; De Stefano F; De Marco R; Calcagno E; Faraci M; Claudiani F; Manfredini L; Dallorso S; Lanino E; Morreale G
    Bone Marrow Transplant; 2000 Jul; 26(2):219-24. PubMed ID: 10918435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile osteopetrosis; bone marrow transplantation from a cousin donor.
    Taylor GM; Dearden SP; Will AM; Evans DI; Stevens RF; Simon S; Super M; Morrell G; Fergusson WD; Brown IH
    Arch Dis Child; 1995 Nov; 73(5):453-5. PubMed ID: 8554366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.
    Fischer A; Griscelli C; Friedrich W; Kubanek B; Levinsky R; Morgan G; Vossen J; Wagemaker G; Landais P
    Lancet; 1986 Nov; 2(8515):1080-4. PubMed ID: 2877234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for infantile osteopetrosis.
    Eapen M; Davies SM; Ramsay NK; Orchard PJ
    Bone Marrow Transplant; 1998 Nov; 22(10):941-6. PubMed ID: 9849690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful bone-marrow transplantation for infantile malignant osteopetrosis.
    Coccia PF; Krivit W; Cervenka J; Clawson C; Kersey JH; Kim TH; Nesbit ME; Ramsay NK; Warkentin PI; Teitelbaum SL; Kahn AJ; Brown DM
    N Engl J Med; 1980 Mar; 302(13):701-8. PubMed ID: 6986555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
    Anasetti C; Amos D; Beatty PG; Appelbaum FR; Bensinger W; Buckner CD; Clift R; Doney K; Martin PJ; Mickelson E
    N Engl J Med; 1989 Jan; 320(4):197-204. PubMed ID: 2643045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild autosomal recessive osteopetrosis: successful treatment with bone marrow transplant.
    Othman IS; Ibrahim H; Hii KC; Ong GB; Menon BS
    Med J Malaysia; 2009 Dec; 64(4):325-6. PubMed ID: 20954561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.
    Sykes M; Preffer F; McAfee S; Saidman SL; Weymouth D; Andrews DM; Colby C; Sackstein R; Sachs DH; Spitzer TR
    Lancet; 1999 May; 353(9166):1755-9. PubMed ID: 10347989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation.
    Fasth A; Porras O
    Pediatr Transplant; 1999; 3 Suppl 1():102-7. PubMed ID: 10587979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.